311 results on '"METOPROLOL"'
Search Results
2. Age and mean platelet volume-based nomogram for predicting the therapeutic efficacy of metoprolol in Chinese pediatric patients with vasovagal syncope
3. The role of beta-adrenoreceptors in postoperative ileus in rats
4. Development and Validation of a Method for Quantification of Lisinopril, Indapamide, Metoprolol, Valsartan, and Amoldipine in Human Blood Serum by HPLC-MS/MS
5. Electrochemical sensor based on nanocomposite of nickel oxide nanoparticles and polypyrrole for the detection of metoprolol as a doping agent in biological fluids and food samples
6. Use of DREAM to assess relative risks of presence of pharmaceuticals and personal care products from a wastewater treatment plant
7. Metoprolol use is associated with improved outcomes in patients with sepsis-induced cardiomyopathy: an analysis of the MIMIC-IV database
8. A higher peak heart rate during head-up tilt test predicts the therapeutic efficacy of metoprolol in vasovagal syncope
9. A cross-sectional study on metoprolol concentrations in various biological samples and their inter-correlations
10. Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients
11. Sensitive electrochemical detection of doping agent metoprolol between athletes via copper phthalocyanine-modified graphitic carbon nitride electrode: a versatile approach for doping surveillance in food products and biological fluids
12. Stability Indicating RP-UPLC Method for the Quantitative Determination of Degradation Impurities of Benidipine Hydrochloride & Metoprolol Succinate in Combined Dosage Form
13. Box‒Behnken design-assisted development of an eco-friendly thin-layer chromatography‒densitometry method for the quantification of amlodipine besylate, metoprolol succinate, and telmisartan in synthetic mixture using AGREE tool
14. Comparative HPTLC study for simultaneous determination of ivabradine and metoprolol using UV and fluorescence detectors
15. No robust reduction of infarct size and no-reflow by metoprolol pretreatment in adult Göttingen minipigs
16. Effect of hesperetin on the pharmacokinetics of metoprolol succinate in rats
17. Evaluation of the Effect of Metoprolol Dosage on Fat Graft Survival
18. A predictive model of response to metoprolol in children and adolescents with postural tachycardia syndrome
19. Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy
20. Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway
21. Increased Renal Dysfunction, Apoptosis, and Fibrogenesis Through Sympathetic Hyperactivity After Focal Cerebral Infarction
22. Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes
23. Early donepezil monotherapy or combination with metoprolol significantly prevents subsequent chronic heart failure in rats with reperfused myocardial infarction
24. Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction
25. Metoprolol Protects Against Arginine Vasopressin-Induced Cellular Senescence in H9C2 Cardiomyocytes by Regulating the Sirt1/p53/p21 Axis
26. Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study
27. Lactoferrin and Metoprolol Supplementation Increase Mouse Survival in an Experimental LPS-Induced Sepsis Model
28. Intravitreal metoprolol for circumscribed choroidal hemangiomas: a phase I clinical trial
29. Biodegradation of metoprolol in oxic and anoxic hyporheic zone sediments: unexpected effects on microbial communities
30. Determination of Thermodynamics Constant of Interaction among of Atenolol and Metoprolol with Human Serum Albumin: Spectroscopic and Molecular Modeling Approaches
31. Better peridialytic blood pressure control using carvedilol in end stage renal disease patients on twice weekly maintenance hemodialysis
32. The Efficacy of Anti-Arrhythmic Drugs in Children With Idiopathic Frequent Symptomatic or Asymptomatic Premature Ventricular Complexes With or Without Asymptomatic Ventricular Tachycardia: a Retrospective Multi-Center Study
33. Optimization of Unidirectional Mucoadhesive Buccal Patches Based on Chitosan and Pluronic® F-127 for Metoprolol Controlled Release: In Vitro and Ex Vivo Evaluations
34. Anesthetic implications and role of preoperative beta blockade in esophageal substitution with stomach in pediatric surgical patients
35. Identifying drug-related attributes to personalise antihypertensive agents: the outcome report of patients receiving metoprolol therapy
36. Metoprolol prevents neuronal dendrite remodeling in a canine model of chronic obstructive sleep apnea
37. Impact of genotype-predicted CYP2D6 metabolism on clinical effects and tolerability of metoprolol in patients after myocardial infarction – a prospective observational study
38. Ganoderic acid A protects neural cells against NO stress injury in vitro via stimulating β adrenergic receptors
39. The effects of intraperitoneal metoprolol administration on healing of bone defects in rat tibia: a pilot study
40. Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure
41. Studies of thermal behavior of metoprolol tartrate
42. Twenty-four-hour urine NE level as a predictor of the therapeutic response to metoprolol in children with recurrent vasovagal syncope
43. Effects of Insulin, Metoprolol and Deferoxamine on Fat Graft Survival
44. Ivabradine preserves dynamic sympathetic control of heart rate despite inducing significant bradycardia in rats
45. Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study
46. Evaluation of anti-hypertensive activity of ancient Unani cardiovascular drug “Saad Kufi” (Cyperus scariosus) in adrenaline-induced hypertensive rats
47. Metoprolol blunts the time-dependent progression of infarct size
48. Metoprolol alleviates arginine vasopressin-induced cardiomyocyte hypertrophy by upregulating the AKT1–SERCA2 cascade in H9C2 cells
49. Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites
50. Left Ventricular Ejection Fraction and Fractional Shortening are Useful for the Prediction of the Therapeutic Response to Metoprolol in Children with Vasovagal Syncope
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.